• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质基质细胞的治疗应用:旁分泌作用及潜在改善。

Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.

机构信息

Department of Tissue Regeneration, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.

出版信息

Tissue Eng Part B Rev. 2012 Apr;18(2):101-15. doi: 10.1089/ten.TEB.2011.0488. Epub 2011 Dec 22.

DOI:10.1089/ten.TEB.2011.0488
PMID:21995703
Abstract

Among the various types of cell-to-cell signaling, paracrine signaling comprises those signals that are transmitted over short distances between different cell types. In the human body, secreted growth factors and cytokines instruct, among others, proliferation, differentiation, and migration. In the hematopoietic stem cell (HSC) niche, stromal cells provide instructive cues to stem cells via paracrine signaling and one of these cell types, known to secrete a broad panel of growth factors and cytokines, is mesenchymal stromal cells (MSCs). The factors secreted by MSCs have trophic, immunomodulatory, antiapoptotic, and proangiogenic properties, and their paracrine profile varies according to their initial activation by various stimuli. MSCs are currently studied as treatment for inflammatory diseases such as graft-versus-host disease and Crohn's disease, but also as treatment for myocardial infarct and solid organ transplantation. In addition, MSCs are investigated for their use in tissue engineering applications, in which their differentiation plays an important role, but as we have recently demonstrated, their trophic factors may also be involved. Furthermore, a functional improvement of MSCs might be obtained after preconditioning or tailoring the cells themselves. Also, the way the cells are clinically administered may be specialized for specific therapeutic scenarios. In this review we will first discuss the HSC niche, in which MSCs were recently identified and are thought to play an instructive and supportive role. We will then evaluate therapeutic applications that currently try to utilize the trophic and/or immunomodulatory properties of MSCs, and we will also discuss new options to enhance their therapeutic effects.

摘要

在各种细胞间信号传递方式中,旁分泌信号是指在不同类型的细胞之间通过短距离传递的信号。在人体中,分泌的生长因子和细胞因子除其他外,可指示增殖、分化和迁移。在造血干细胞 (HSC) 龛位中,基质细胞通过旁分泌信号向干细胞提供指导信号,其中一种已知分泌广泛的生长因子和细胞因子的细胞类型是间充质基质细胞 (MSCs)。MSCs 分泌的因子具有营养、免疫调节、抗凋亡和促血管生成特性,其旁分泌谱根据其对各种刺激的初始激活而变化。MSCs 目前被研究用于治疗炎症性疾病,如移植物抗宿主病和克罗恩病,也用于治疗心肌梗死和实体器官移植。此外,MSCs 还用于组织工程应用的研究,在该应用中,其分化起着重要作用,但正如我们最近所证明的那样,其营养因子也可能参与其中。此外,通过预处理或定制细胞本身,可以获得 MSCs 的功能改善。同样,细胞的临床给药方式也可能针对特定的治疗情况进行专门化。在这篇综述中,我们将首先讨论 HSC 龛位,最近在该龛位中鉴定出 MSCs,并且认为它们具有指导和支持作用。然后,我们将评估目前试图利用 MSCs 的营养和/或免疫调节特性的治疗应用,并讨论增强其治疗效果的新选择。

相似文献

1
Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.间充质基质细胞的治疗应用:旁分泌作用及潜在改善。
Tissue Eng Part B Rev. 2012 Apr;18(2):101-15. doi: 10.1089/ten.TEB.2011.0488. Epub 2011 Dec 22.
2
Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.多能间充质基质细胞产生的分化因子对骨髓间充质干细胞发挥旁分泌作用:对骨再生中旁分泌作用的启示。
Biochem Biophys Res Commun. 2012 Oct 5;426(4):475-9. doi: 10.1016/j.bbrc.2012.08.095. Epub 2012 Aug 29.
3
Potential therapeutic applications of mesenchymal stromal cells.间充质基质细胞的潜在治疗应用。
Pathology. 2011 Oct;43(6):592-604. doi: 10.1097/PAT.0b013e32834ab72d.
4
Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.预处理间充质基质细胞球以分泌免疫调节旁分泌因子。
Cytotherapy. 2014 Mar;16(3):331-45. doi: 10.1016/j.jcyt.2013.09.004. Epub 2013 Nov 9.
5
Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.基于间充质干细胞治疗的旁分泌机制:现状与展望
Cell Transplant. 2014;23(9):1045-59. doi: 10.3727/096368913X667709.
6
Mesenchymal stromal cells.间充质基质细胞
Ann N Y Acad Sci. 2009 Sep;1176:101-17. doi: 10.1111/j.1749-6632.2009.04607.x.
7
Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects.解析间充质基质细胞的旁分泌免疫调节作用
Transfus Med Rev. 2016 Jan;30(1):37-43. doi: 10.1016/j.tmrv.2015.11.004. Epub 2015 Dec 1.
8
Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention.人类间充质基质细胞蛋白质组学:为医学干预的新标志物和靶点的鉴定做出贡献。
Expert Rev Proteomics. 2012 Apr;9(2):217-30. doi: 10.1586/epr.12.9.
9
Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.基于间充质干细胞的实验和临床试验:现状和待解决的问题。
Expert Opin Biol Ther. 2011 Jul;11(7):893-909. doi: 10.1517/14712598.2011.574119. Epub 2011 Mar 30.
10
Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?用于治疗心力衰竭的骨髓间充质干细胞:全是旁分泌作用和免疫调节吗?
J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):122-8. doi: 10.2459/JCM.0b013e32820588f0.

引用本文的文献

1
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies.间充质干细胞在治疗人类疾病中的应用:分子机制与临床研究
Signal Transduct Target Ther. 2025 Aug 22;10(1):262. doi: 10.1038/s41392-025-02313-9.
2
Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton's Jelly Mesenchymal Stromal Cells.含有华通氏胶间充质基质细胞的同种异体骨组织工程产品在幼年绵羊中的临床前评估
Cells. 2025 Jun 7;14(12):862. doi: 10.3390/cells14120862.
3
Amniotic fluid-derived mesenchymal stem cells as a therapeutic tool against cytokine storm: a comparison with umbilical cord counterparts.
羊水来源的间充质干细胞作为对抗细胞因子风暴的治疗工具:与脐带来源的间充质干细胞的比较
Stem Cell Res Ther. 2025 Mar 28;16(1):151. doi: 10.1186/s13287-025-04262-0.
4
An overview of stem cells and cell products involved in trauma injury.创伤损伤中涉及的干细胞和细胞产物概述。
Regen Ther. 2025 Mar 11;29:60-76. doi: 10.1016/j.reth.2025.02.011. eCollection 2025 Jun.
5
State-of the-art and future perspective in co-culture systems for tendon engineering.用于肌腱工程的共培养系统的现状与未来展望。
Biomater Biosyst. 2025 Mar 5;17:100110. doi: 10.1016/j.bbiosy.2025.100110. eCollection 2025 Mar.
6
Effect of Hyaluronic Acid Compared to Platelet-Rich Plasma as Adjuvants to Bone Marrow Mesenchymal Stem Cell Treatment of Knee Osteoarthritis: Analysis from Two Clinical Trials.与富血小板血浆相比,透明质酸作为骨髓间充质干细胞治疗膝骨关节炎辅助剂的效果:来自两项临床试验的分析
Diagnostics (Basel). 2025 Jan 28;15(3):309. doi: 10.3390/diagnostics15030309.
7
The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.组织修复与再生中干细胞分泌组的范例:现状与未来展望。
Wound Repair Regen. 2025 Jan-Feb;33(1):e13251. doi: 10.1111/wrr.13251.
8
Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation - the Karolinska experience.与在医院隔离相比,接受同种异体造血细胞移植的患者在家庭护理中接受治疗具有更好的临床结局和更低的炎症细胞因子触发率 - 卡罗林斯卡经验。
Front Immunol. 2024 Aug 7;15:1384137. doi: 10.3389/fimmu.2024.1384137. eCollection 2024.
9
Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders.改善临床试验的未来和间充质基质细胞疗法在新生儿疾病中的转化。
Stem Cells Transl Med. 2024 Oct 10;13(10):941-948. doi: 10.1093/stcltm/szae060.
10
TWCOM: an R package for inference of cell-cell communication on spatially resolved transcriptomics data.TWCOM:一个用于在空间分辨转录组学数据上进行细胞间通讯推断的R包。
Bioinform Adv. 2024 Jul 16;4(1):vbae101. doi: 10.1093/bioadv/vbae101. eCollection 2024.